Drug distributor that paid $20M fine exits opioid sales because of costs of legal risks

A New York drug distributor will no longer sell opioids, saying the legal costs associated with them are just too high. Those costs, of course, include the $20 million the company paid to defer federal criminal charges and the costs after two of its execs were charged last year with felonies for the company’s opioid sales practices.